Sagimet Biosciences (SGMT) Invested Capital: 2023-2024
Historic Invested Capital for Sagimet Biosciences (SGMT) over the last 2 years, with Sep 2024 value amounting to $170.7 million.
- Sagimet Biosciences' Invested Capital rose 74.39% to $170.7 million in Q3 2024 from the same period last year, while for Sep 2024 it was $170.7 million, marking a year-over-year increase of 74.39%. This contributed to the annual value of $91.1 million for FY2023, which is N/A change from last year.
- Per Sagimet Biosciences' latest filing, its Invested Capital stood at $170.7 million for Q3 2024, which was down 6.88% from $183.3 million recorded in Q2 2024.
- Over the past 5 years, Sagimet Biosciences' Invested Capital peaked at $190.0 million during Q1 2024, and registered a low of -$198.4 million during Q2 2023.
- In the last 2 years, Sagimet Biosciences' Invested Capital had a median value of $134.3 million in 2023 and averaged $89.1 million.
- Data for Sagimet Biosciences' Invested Capital shows a peak YoY soared of 192.38% (in 2024) over the last 5 years.
- Sagimet Biosciences' Invested Capital (Quarterly) stood at $91.1 million in 2023, then surged by 74.39% to $170.7 million in 2024.
- Its last three reported values are $170.7 million in Q3 2024, $183.3 million for Q2 2024, and $190.0 million during Q1 2024.